ARCHIVES

Wender Named ACS Chief Cancer Control Officer

This article is from The Cancer Letter archive.

Vol. 39 No. 32 | August 9, 2013

Download PDF Visit The Full Archive

Related Articles

California Hospital Raises $22 Million For New Cancer Center

September 14, 1990

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

New Cancer Control Projects Aimed At Upgrading Care At Community Level; 56 Contracts Anticipated

November 15, 1974

NCI, Dialogue Plan A National Tissue Bank

July 11, 2003